Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Darby

Showing results (41-50 of 81) with videos related to

Pageof 9
Sort By:
Multiple Sclerosis and Related Disorders|February 26, 2022
Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive testsDaniel Merlo, Tomas Kalincik, Chao Zhu, et al.
The Journal of Prevention of Alzheimer'S Disease|February 19, 2025
Real-world datasets for the International Registry for Alzheimer's Disease and Other Dementias (InRAD) and other registries: An international consensusRobert Perneczky, David Darby, Giovanni B Frisoni, et al.
Frontiers in Neurology|November 8, 2021
Neurodegeneration Over 3 Years Following Ischaemic Stroke: Findings From the Cognition and Neocortical Volume After Stroke StudyAmy Brodtmann, Emilio Werden, Mohamed Salah Khlif, et al.
Multiple Sclerosis and Related Disorders|June 1, 2020
The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosisCharmaine Yam, Daniel Merlo, Jim Stankovich, et al.
BMC Psychology|January 8, 2015
Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's diseasePaul Maruff, Yen Ying Lim, David Darby, et al.
Neurology|September 24, 2021
Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple SclerosisDaniel Merlo, Jim Stankovich, Claire Bai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2012
Aβ amyloid, cognition, and APOE genotype in healthy older adultsYen Ying Lim, Kathryn A Ellis, David Ames, et al.
Journal of Clinical and Experimental Neuropsychology|January 18, 2012
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyYen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
BMJ Open|November 17, 2020
A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementiaLucy Vivash, Charles B Malpas, Leonid Churilov, et al.
Neurology|October 17, 2012
Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adultsYen Ying Lim, Kathryn A Ellis, Robert H Pietrzak, et al.
Pageof 9

Showing results (41-50 of 81) with videos related to

Sort By:
Pageof 9
Multiple Sclerosis and Related Disorders|February 26, 2022
Subjective versus objective performance in people with multiple sclerosis using the MSReactor computerised cognitive testsDaniel Merlo, Tomas Kalincik, Chao Zhu, et al.
The Journal of Prevention of Alzheimer'S Disease|February 19, 2025
Real-world datasets for the International Registry for Alzheimer's Disease and Other Dementias (InRAD) and other registries: An international consensusRobert Perneczky, David Darby, Giovanni B Frisoni, et al.
Frontiers in Neurology|November 8, 2021
Neurodegeneration Over 3 Years Following Ischaemic Stroke: Findings From the Cognition and Neocortical Volume After Stroke StudyAmy Brodtmann, Emilio Werden, Mohamed Salah Khlif, et al.
Multiple Sclerosis and Related Disorders|June 1, 2020
The MSReactor computerized cognitive battery correlates with the processing speed test in relapsing-remitting multiple sclerosisCharmaine Yam, Daniel Merlo, Jim Stankovich, et al.
BMC Psychology|January 8, 2015
Clinical utility of the cogstate brief battery in identifying cognitive impairment in mild cognitive impairment and Alzheimer's diseasePaul Maruff, Yen Ying Lim, David Darby, et al.
Neurology|September 24, 2021
Association Between Cognitive Trajectories and Disability Progression in Patients With Relapsing-Remitting Multiple SclerosisDaniel Merlo, Jim Stankovich, Claire Bai, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|November 20, 2012
Aβ amyloid, cognition, and APOE genotype in healthy older adultsYen Ying Lim, Kathryn A Ellis, David Ames, et al.
Journal of Clinical and Experimental Neuropsychology|January 18, 2012
Use of the CogState Brief Battery in the assessment of Alzheimer's disease related cognitive impairment in the Australian Imaging, Biomarkers and Lifestyle (AIBL) studyYen Ying Lim, Kathryn A Ellis, Karra Harrington, et al.
BMJ Open|November 17, 2020
A study protocol for a phase II randomised, double-blind, placebo-controlled trial of sodium selenate as a disease-modifying treatment for behavioural variant frontotemporal dementiaLucy Vivash, Charles B Malpas, Leonid Churilov, et al.
Neurology|October 17, 2012
Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adultsYen Ying Lim, Kathryn A Ellis, Robert H Pietrzak, et al.
Pageof 9